Invitrogen Corporation (NASDAQ:IVGN) is a global company with revenues of $1.3 billion. We provide products and services to pharmaceutical and biotechnology companies, as well as academic and government research institutions. More than 4,700 employees work for Invitrogen and we conduct business in over 70 countries. We offer 35,000 unique products and services to support disease research, drug discovery and commercial bio-production. Invitrogen’s product family includes many of the most wide...